This inventor holds 4 USPTO granted patents. Top assignee: Mochida Pharmaceutical Co., Ltd.. Active years: 1996-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (1996 - 2000)
- Shinjuku-ku, JP (2003 - 2004)
Company Filing History:
Years Active: 1996-2004
Title: Manabu Itoh: Innovator in Pharmaceutical Advancements
Introduction: Manabu Itoh, an esteemed inventor based in Shinjuku-ku, Japan, has significantly contributed to the field of pharmaceuticals with his innovative research and development. With four patents to his name, Itoh's work primarily focuses on breakthroughs that address critical health challenges, highlighting his commitment to advancing medical science.
Latest Patents: Manabu Itoh's latest patents include groundbreaking discoveries such as "4-hydroxypiperidine derivatives having antiarrhythmic activity" and "agents for treating neuropathic pain." These innovations exemplify his expertise in developing novel pharmaceutical agents that can improve patient outcomes and enhance therapeutic options for various medical conditions.
Career Highlights: Itoh currently works at Mochida Pharmaceutical Co., Ltd., a company renowned for its dedication to advancing healthcare through innovation. His role as an inventor is marked by a strong focus on discovering new treatments that address unmet medical needs, which has established him as a crucial figure in the pharmaceutical industry.
Collaborations: Throughout his career, Manabu Itoh has collaborated with talented professionals including Ichiro Yamamoto and Yasushige Akada. These partnerships have further enriched his research endeavors and contributed to the successful development of patented innovations, demonstrating the power of teamwork in scientific advancement.
Conclusion: Manabu Itoh's impressive portfolio of four patents and his role at Mochida Pharmaceutical Co., Ltd. underscore his impact on the pharmaceutical field. His commitment to innovation not only enhances therapeutic options for patients but also signifies a key contribution to the ongoing evolution of medical science in Japan and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile